Navigation Links
Dr. Richard Charmoy Launches Groundbreaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
Date:3/27/2013

(PRWEB) March 27, 2013

Dental decay is the number one chronic disease affecting American youth; surpassing both obesity and asthma. For Dr. Charmoy of Somerville, New Jersey those statistics are no longer daunting. He and his team have taken the top caries research in the world and implemented a cavity prevention program developed by CariFree that is shown to decrease incidents of tooth decay by up to 74%. The system is known as CAMBRA or Caries Management by Risk Assessment. Dr. Charmoy states: “I think this is a revolution in dentistry, comparable to the introduction of fluoride. This system visually shows the patient, doctor and hygienist the level of bacteria that cause decay for each patient. If the levels can be reduced the patient is less likely to see decay in future. CariFree has developed a line of products to help lower this level in the patient’s mouth.”

CAMBRA is rooted in a medical model of risk assessment. It requires the dental professional to assess each and every patient’s risk factors for the disease and then develop a personalized treatment plan to systematically lower their risk. The CariFree diagnostic tools leverage biofilm testing (to determine the levels of cavity-causing bacteria in the patient’s mouth) as well as a risk assessment questionnaire to determine the overall statistical probability a patient will develop new cavities over the next 12 months. Never before has such predictive information been available. Patients can then measurably lower their risk for decay by utilizing professional products and behavior modification.

Patients can expect the entire process to take a few minutes in their appointment. They will answer targeted questions regarding their current habits (eating and drinking, medication use, chronic health issues etc.) as well as undergo a quick, painless swab of their lower teeth (to determine if they have an excess of cavity causing bacteria). Dr. Charmoy says: “There is no cost for doing this procedure, depending upon the level of bacteria, we can determine the proper products you need which the office can provide.”

Based on the information gathered, the dental team will counsel each patient on an appropriate course of action to lower their risk. If professional products are recommended the team will provide patients with a professional kit of product specifically designed to counteract their risk factors.

Science has proven that this disease cannot be stopped by the drill and fill approach. True cure requires a medical approach and a comprehensive assessment of each patient. Dr. Charmoy has taken a bold and caring step for their patients and their community. Dr. Charmoy says: “Dentists and hygienists work hard to help patients prevent decay. Because of CariFree, fluoride and sealants; we will eventually see a cavity free generation. This is also great for adults who have had a long history of decay and are seeing recurrent decay around those fillings. The bacteria are not related to age of patient, we all have some level of the bacteria so finding out the amount is critical. CariFree is a system that we can be beneficial to the whole family.”

For more information on the CariFree system, go to http://www.carifree.com. To make your appointment with Dr. Charmoy and his team call (908)722-9222

About Dr. Charmoy: Dr. Charmoy lives in Bridgewater and has been practicing dentistry in Somerville for over 25 years. He recently built a news office to keep up with the newest technology. Dr. Charmoy is a graduate of the University of Utah. He studied biochemistry at Seton Hall University and Fairleigh Dickson School of Dentistry where he obtained his dental degree. Before becoming a dentist Dr. Charmoy worked as a dental technician, eventually managed a lab. This experience allowed Dr. Charmoy to graduate near the top of his class.

He lives with his wife and their two dogs who come to work every day with Dr. Charmoy. He has a son and daughter and recently became a grandfather. He is an avid reader of fiction and the latest studies in dentistry journals. Dr. Charmoy strives to stay abreast of the latest technology in order to provide the highest quality dentistry for his patients.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10572386.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Book on Richard Feynman nets honors for Arizona State professor
2. Richard H. Scheuermann, Ph.D. Joins J. Craig Venter Institute as Director of Informatics
3. Fish & Richardson Principals Named "Life Sciences IP Stars" for 2012 by LMG Life Sciences
4. Islet Sciences Names Richard A. Franco, Sr. to its Board of Directors
5. BioHealth Innovation, Inc. President & CEO Richard Bendis to Present at SXSW 2013 & 2013 BIO International Convention
6. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
7. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
8. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
9. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
10. Neogen Launches Fully Quantitative Lateral Flow Test for DON
11. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... , ... December 06, 2019 ... ... Vascular Medcure, Inc. has received FDA 510(k) clearance for its latest CAPERE® ... early clinical data suggests the CAPERE® offers great benefits for first-in-line treatment ...
(Date:12/4/2019)... ... ... A new survey by MedReps ( http://www.medreps.com ), a career site for ... sales companies to work for in 2020. , The 9th Annual Best ... MedReps community to identify which medical sales companies are currently the most sought-after in ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of ... San Francisco (UCSF) with a common goal to generate recombinant antibodies at a ...
(Date:12/4/2019)... ... December 03, 2019 , ... Bold Brahim aka Jesse, a ... right front leg. After several weeks of medical management, his condition worsened so his ... California Equine Orthopedics . Results revealed Jesse had a severe injury to his deep ...
Breaking Biology Technology:
(Date:12/4/2019)... BASEL, Switzerland (PRWEB) , ... December 03, 2019 ... ... for biopharmaceutical R&D, today announced that Agenus , a clinical-stage immuno-oncology company ... part of their antibody R&D workflow platform. Agenus will use the platform to ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... Ethicann Pharmaceuticals Inc. (“Ethicann”), a Calgary-based pharmaceutical company using botanically sourced cannabinoid ...
(Date:12/4/2019)... ... December 04, 2019 , ... NDA Partners ... , a regulatory toxicology expert with more than 20 years of experience working ... , Dr. Todd has extensive experience with a variety of biologic modalities including ...
Breaking Biology News(10 mins):